Insider · CIK 0001982655
Philip J Gotwals
Files at CAPR (CAPRICOR THERAPEUTICS, INC.), OABI (OmniAb, Inc.). First filing -, latest -.
Philip J Gotwals files SEC Form 4 as director at CAPR (CAPRICOR THERAPEUTICS, INC.), and also at OABI (OmniAb, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Philip J Gotwals has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | OABI OmniAb, Inc. | MOption exercise Common Stock | +20,000 | - | - | 33,333 | Jun 18, 2026 |
| Jun 17, 2026 | OABI OmniAb, Inc. | MOption exercise Restricted Stock Unitsderivative | -20,000 | $0.00 | $0 | 26,667 | Jun 18, 2026 |
| Jun 17, 2026 | OABI OmniAb, Inc. | AGrant or award Restricted Stock Unitsderivative | +20,000 | $0.00 | $0 | 46,667 | Jun 18, 2026 |
| Jun 17, 2026 | OABI OmniAb, Inc. | AGrant or award Stock Option (right to buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jun 18, 2026 |
| Apr 21, 2026 | OABI OmniAb, Inc. | MOption exercise Common Stock | +13,333 | - | - | 13,333 | Apr 21, 2026 |
| Apr 21, 2026 | OABI OmniAb, Inc. | MOption exercise Restricted Stock Unitsderivative | -13,333 | $0.00 | $0 | 46,667 | Apr 21, 2026 |
| Jan 5, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +15,500 | $0.00 | $0 | 15,500 | Jan 7, 2026 |
| Jun 17, 2025 | OABI OmniAb, Inc. | AGrant or award Restricted Stock Unitsderivative | +20,000 | $0.00 | $0 | 60,000 | Jun 18, 2025 |
| Jun 17, 2025 | OABI OmniAb, Inc. | AGrant or award Stock Option (right to buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jun 18, 2025 |
| Apr 21, 2025 | OABI OmniAb, Inc. | AGrant or award Restricted Stock Unitsderivative | +40,000 | $0.00 | $0 | 40,000 | Apr 21, 2025 |
| Apr 21, 2025 | OABI OmniAb, Inc. | AGrant or award Stock Option (right to buy)derivative | +80,000 | $0.00 | $0 | 80,000 | Apr 21, 2025 |
| Jan 2, 2025 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +11,940 | $0.00 | $0 | 11,940 | Jan 6, 2025 |
| Jan 2, 2025 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +2,160 | $0.00 | $0 | 2,160 | Jan 6, 2025 |
| Jan 2, 2025 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +5,750 | $0.00 | $0 | 5,750 | Jan 6, 2025 |
Questions about Philip J Gotwals
Answered from the filings on this page, as of the latest one.
Is Philip J Gotwals buying or selling?
Philip J Gotwals has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Philip J Gotwals's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Philip J Gotwals has 0.
Where does Philip J Gotwals file Form 4?
Philip J Gotwals has filed Form 4 at CAPR (CAPRICOR THERAPEUTICS, INC.); OABI (OmniAb, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.